To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...

The bone marrow environment evolves in ways that support the cancer, and I’m a firm believer that to treat cancer effectively ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have made a breakthrough in cancer ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

In a syngeneic mouse model, the suppression of DDX54 led to significant increases in the infiltration of anti-cancer immune ...